Overview

• Autodoc canceled its planned initial public offering after banks signaled that share demand was weak and the allocation price landed in the lower third of the €58–59 range
• This marks the company’s second aborted IPO after the original 2021 listing was halted due to unfavorable market conditions
• The offering had been structured to raise about €450 million with a valuation exceeding €2.2 billion
• Had it proceeded, Autodoc would have been the first new listing in the Deutsche Börse’s Prime Standard segment in 2025
• Autodoc’s founders and major investor Apollo said they will continue to evaluate a future IPO when market conditions improve